SoluLinK Introduces NanoLink(TM) Streptavidin Magnetic Microspheres
Highest Binding Capacity on the Market. SoluLinK, San Diego, California. (PRNewsFoto/SoluLinK, Inc.) SAN DIEGO, May 28 — SoluLinK, Inc., a leader in next-generation conjugation products and kits, is proud to announce the introduction of a new product, NanoLink(TM) Streptavidin Magnetic Microspheres. These sub-micron particles possess the highest biotin-binding capacity of any commercially available polymer-encapsulated streptavidin magnetic microsphere. NanoLink(TM) Streptavidin particles are particularly suited for high throughput robotic applications where high biotin loads must be removed or immobilized without the presence of an iron leachate. Features and Benefits include: — Highest free-biotin binding capacity > 12 nmol/mg — Highest biotin-oligonucleotide binding capacity > 2.5 nmol/mg — Highest biotin-IgG binding capacity > 1.7 nmol/mg (250 ug) — Higher capacity means less mass and lower background (NSB) — Higher capacity means significantly lower net costs — Encapsulated (no exposed iron) polymeric microspheres — Fast magnetic response time (1-2 minutes) (Photo: http://www.newscom.com/cgi-bin/prnh/20080528/LAW512) “NanoLink(TM) Streptavidin Magnetic Microspheres represent a continuation of our development efforts in leveraging SoluLinK’s next-generation conjugation technology into formats that enable our customers’ and collaborators’ to build greater value into their products and research,” observed Leo Mendoza, Director of Product Development. About SoluLinK SoluLinK is a leader in the development, manufacturing and marketing of advanced conjugation reagents (HydraLink(TM)) biotinylation kits (ChromaLink(TM)), magnetic microspheres (NanoLink(TM)), detection reagents and conjugating services for the life sciences, diagnostic, and pharmaceutical communities. The company’s proprietary bioconjugation chemistry is used to link proteins, oligonucleotides, peptides, and antibodies to each other or to a wide range of surfaces. Rapidly growing applications for SoluLinK’s products include the conjugation of biomolecules used in research assays, diagnostics, and various pharmaceutical products. The company markets its products directly and through partner-associated distributors world-wide. Technology licenses are available. SoluLinK is a privately held company located in San Diego, California. For more information, please visit http://www.solulink.com.